The Doctor Care Anywhere Group PLC (ASX: DOC) share price is up more than 11% today after announcing some positive UK news.
The positive update
The UK-based telehealth business has signed heads of terms with Nuffield Health, one of the UK’s largest private healthcare organisations, to develop a digitally integrated virtual and in-person primary care service.
Pre-marketing to Nuffield Health’s network of 1,600 corporate clients will commence immediately.
Launching in the fourth quarter of 2021, this partnership will allow patients access to Doctor Care Anywhere’s 24/7 virtual GP service and Nuffield Health’s nationwide network of face to face GPs. It’s the first nationally integrated primary care proposition in the UK.
It is estimated that approximately 70% of all primary care consultations can be conducted virtually. By integrating an in-person GP service, Doctor Care anywhere will be able to increase the scope and volume of primary care consultations offered to patients.
Management said that this new approach demonstrates digital healthcare’s ability to transform health journeys by giving patients the choice of how, when and where they access primary care. The integration will also allow patients to have access to an expanded scope of clinical services which can be booked, reviewed and followed up on one digital platform.
Another market update will be released to the market after signing the full contract.
Management comments
The CEO and founder of Doctor Care Anywhere, Dr Bayju Thakar, said: “This represents a true shift in how healthcare can and should be delivered on a national scale and at a time when there is huge pressure on primary care systems across the UK offers real improvements in terms of convenience, cost and quality of the care experience.”
Summary thoughts on the Doctor Care Anywhere share price
The Doctor Care Anywhere share price has fallen heavily quite a lot from earlier this year, despite today’s rise.
It’s a very interesting business model and it seems to be getting real traction. The UK is a very big market, so I think it’s one of the ASX growth shares to keep an eye on for the longer-term.
